Back to today’s briefing

Story perspectives

Semaglutide: HIV Treatment Promises Health Boosts Amid Access Barriers

4/24/2025

48 5

Summary

Story summary

Semaglutide, a GLP-1 receptor agonist, shows promise for people living with HIV, potentially reducing inflammation, boosting cognitive function, and improving gut health. It also curbs alcohol cravings and may slow biological aging. Yet, significant barriers remain, particularly for Black and Latino communities, limiting access to this groundbreaking treatment.

1 of 1

Story summary

Semaglutide, a GLP-1 receptor agonist, shows promise for people living with HIV, potentially reducing inflammation, boosting cognitive function, and improving gut health. It also curbs alcohol cravings and may slow biological aging. Yet, significant barriers remain, particularly for Black and Latino communities, limiting access to this groundbreaking treatment.